Literature DB >> 11980606

Noncompliance with tuberculosis treatment by patients at a tuberculosis and AIDS reference hospital in midwestern Brazil.

Marcelo Fouad Rabahi1, Adriana Batista Rodrigues, Fernanda Queiroz de Mello, Joaquim Caetano de Almeida Netto, Afrânio Lineu Kritski.   

Abstract

INTRODUCTION: In developing countries, there is little information about the risk factors that predict noncompliance with tuberculosis (TB) treatment in hospitals.
OBJECTIVE: This study analyzes possible factors associated with noncompliance with TB treatment among patients treated at HAA.
DESIGN: A retrospective cohort study was made including all patients who initiated TB treatment at HAA, from January to December 1998. A standard form was used to review medical records and to collect data on each patient. This data was evaluated in comparison with data from the state TB control program.
RESULTS: Of the 341 patients included in the study, 186 (61.2%) were considered cured and 67 (22%) were non-compliant. The factors associated with noncompliance were: previous anti-TB treatment (RR = 1.95, 95% CI 1.29 to 2.93), prescription of drugs other than the standard first-line regimen proposed by the Brazilian Health Ministry (Rifampin + Isoniazide + Pyrazinamide) (RR = 0.54, 95% CI 0.35 to 0.83), the need for hospitalization (RR = 2.19, 95% CI 1.46 to 3.29) and non-inclusion in the hospital s TB Control Program for treatment follow up (RR = 0.54, 95% CI 0.35 to 0.82).
SETTING: Anuar Auad Hospital (HAA) Goiânia, Goiás, Brazil.
CONCLUSION: Our results indicate the importance of establishing Tuberculosis Control Programs in hospitals, while paying special attention to patients with risk factors for noncompliance with TB treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11980606     DOI: 10.1590/s1413-86702002000200002

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  6 in total

1.  Sputum Collection and Disposal Perceptions and Practices Among Pulmonary Tuberculosis Patients from Northern India.

Authors:  Abhishek Singh; Vipin Goyal; Shewtank Goel
Journal:  J Clin Diagn Res       Date:  2016-12-01

2.  Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort study.

Authors:  Magda Maruza; Maria F P Militão Albuquerque; Isabella Coimbra; Líbia V Moura; Ulisses R Montarroyos; Demócrito B Miranda Filho; Heloísa R Lacerda; Laura C Rodrigues; Ricardo A A Ximenes
Journal:  BMC Infect Dis       Date:  2011-12-16       Impact factor: 3.090

3.  Humoral response to HspX and GlcB to previous and recent infection by Mycobacterium tuberculosis.

Authors:  Marcelo Fouad Rabahi; Ana Paula Junqueira-Kipnis; Michelle Cristina Guerreiro Dos Reis; Walter Oelemann; Marcus Barreto Conde
Journal:  BMC Infect Dis       Date:  2007-12-31       Impact factor: 3.090

4.  Clinical treatment outcomes of tuberculosis treated with the basic regimen recommended by the Brazilian National Ministry of Health using fixed-dose combination tablets in the greater metropolitan area of Goiânia, Brazil.

Authors:  Anna Carolina Galvão Ferreira; José Laerte Rodrigues da Silva Júnior; Marcus Barreto Conde; Marcelo Fouad Rabahi
Journal:  J Bras Pneumol       Date:  2013 Jan-Feb       Impact factor: 2.624

5.  A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?

Authors:  Lisa Kawatsu; Kazuhiro Uchimura; Akihiro Ohkado; Seiya Kato
Journal:  PLoS One       Date:  2018-06-15       Impact factor: 3.240

6.  Clinical and epidemiological characteristics associated with unfavorable tuberculosis treatment outcomes in TB-HIV co-infected patients in Brazil: a hierarchical polytomous analysis.

Authors:  Thiago Nascimento do Prado; Jayant V Rajan; Angélica Espinosa Miranda; Elias Dos Santos Dias; Lorrayne Beliqui Cosme; Lia Gonçalves Possuelo; Mauro N Sanchez; Jonathan E Golub; Lee W Riley; Ethel Leonor Maciel
Journal:  Braz J Infect Dis       Date:  2016-12-06       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.